189 related articles for article (PubMed ID: 30165243)
1. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
Delanne J; Nambot S; Chassagne A; Putois O; Pelissier A; Peyron C; Gautier E; Thevenon J; Cretin E; Bruel AL; Goussot V; Ghiringhelli F; Boidot R; Tran Mau-Them F; Philippe C; Vitobello A; Demougeot L; Vernin C; Lapointe AS; Bardou M; Luu M; Binquet C; Lejeune C; Joly L; Juif C; Baurand A; Sawka C; Bertolone G; Duffourd Y; Sanlaville D; Pujol P; Geneviève D; Houdayer F; Thauvin-Robinet C; Faivre L
Eur J Med Genet; 2019 Jun; 62(6):103529. PubMed ID: 30165243
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
[TBL] [Abstract][Full Text] [Related]
3. The impact of unsolicited findings in clinical exome sequencing, a qualitative interview study.
Schoot VV; Viellevoije SJ; Tammer F; Brunner HG; Arens Y; Yntema HG; Oerlemans AJM
Eur J Hum Genet; 2021 Jun; 29(6):930-939. PubMed ID: 33637888
[TBL] [Abstract][Full Text] [Related]
4. Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives.
Houdayer F; Putois O; Babonneau ML; Chaumet H; Joly L; Juif C; Michon CC; Staraci S; Cretin E; Delanoue S; Charron P; Chassagne A; Edery P; Gautier E; Lapointe AS; Thauvin-Robinet C; Sanlaville D; Gargiulo M; Faivre L
Eur J Med Genet; 2019 Oct; 62(10):103711. PubMed ID: 31265899
[TBL] [Abstract][Full Text] [Related]
5. Shortened consent forms for genome-wide sequencing: Parent and provider perspectives.
Hitchcock EC; Study C; Elliott AM
Mol Genet Genomic Med; 2020 Jul; 8(7):e1254. PubMed ID: 32383361
[TBL] [Abstract][Full Text] [Related]
6. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
7. Defining categories of actionability for secondary findings in next-generation sequencing.
Moret C; Mauron A; Fokstuen S; Makrythanasis P; Hurst SA
J Med Ethics; 2017 May; 43(5):346-349. PubMed ID: 28039284
[TBL] [Abstract][Full Text] [Related]
8. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings.
Sapp JC; Facio FM; Cooper D; Lewis KL; Modlin E; van der Wees P; Biesecker LG
Genet Med; 2021 Dec; 23(12):2260-2269. PubMed ID: 34433902
[TBL] [Abstract][Full Text] [Related]
9. Parents, their children, whole exome sequencing and unsolicited findings: growing towards the child's future autonomy.
Tibben A; Dondorp W; Cornelis C; Knoers N; Brilstra E; van Summeren M; Bolt I
Eur J Hum Genet; 2021 Jun; 29(6):911-919. PubMed ID: 33456055
[TBL] [Abstract][Full Text] [Related]
10. Clinical geneticists' views on and experiences with unsolicited findings in next-generation sequencing: "A great technology creating new dilemmas".
van der Schoot V; Damsté C; Yntema HG; Brunner HG; Oerlemans AJM
J Genet Couns; 2023 Apr; 32(2):387-396. PubMed ID: 36366912
[TBL] [Abstract][Full Text] [Related]
11. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.
Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
BMC Med Genomics; 2019 Aug; 12(1):123. PubMed ID: 31429751
[TBL] [Abstract][Full Text] [Related]
12. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
[TBL] [Abstract][Full Text] [Related]
13. Gratitude, protective buffering, and cognitive dissonance: How families respond to pediatric whole exome sequencing in the absence of actionable results.
Werner-Lin A; Zaspel L; Carlson M; Mueller R; Walser SA; Desai R; Bernhardt BA
Am J Med Genet A; 2018 Mar; 176(3):578-588. PubMed ID: 29446570
[TBL] [Abstract][Full Text] [Related]
14. Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study).
Viora-Dupont E; Robert F; Chassagne A; Pélissier A; Staraci S; Sanlaville D; Edery P; Lesca G; Putoux A; Pons L; Cadenes A; Baurand A; Sawka C; Bertolone G; Spetchian M; Yousfi M; Salvi D; Gautier E; Vitobello A; Denommé-Pichon AS; Bruel AL; Tran Mau-Them F; Faudet A; Keren B; Labalme A; Chatron N; Abel C; Dupuis-Girod S; Poisson A; Buratti J; Mignot C; Afenjar A; Whalen S; Charles P; Heide S; Mouthon L; Moutton S; Sorlin A; Nambot S; Briffaut AS; Asensio ML; Philippe C; Thauvin-Robinet C; Héron D; Rossi M; Meunier-Bellard N; Gargiulo M; Peyron C; Binquet C; Faivre L
Eur J Hum Genet; 2024 May; ():. PubMed ID: 38802530
[TBL] [Abstract][Full Text] [Related]
15. How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis.
Vears DF; Niemiec E; Howard HC; Borry P
Clin Genet; 2018 Oct; 94(3-4):321-329. PubMed ID: 29888485
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing in pediatrics: parents' considerations toward return of unsolicited findings for their child.
Cornelis C; Tibben A; Dondorp W; van Haelst M; Bredenoord AL; Knoers N; Düwell M; Bolt I; van Summeren M
Eur J Hum Genet; 2016 Dec; 24(12):1681-1687. PubMed ID: 27460421
[TBL] [Abstract][Full Text] [Related]
17. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
19. High-frequency actionable pathogenic exome variants in an average-risk cohort.
Rego S; Dagan-Rosenfeld O; Zhou W; Sailani MR; Limcaoco P; Colbert E; Avina M; Wheeler J; Craig C; Salins D; Röst HL; Dunn J; McLaughlin T; Steinmetz LM; Bernstein JA; Snyder MP
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30487145
[TBL] [Abstract][Full Text] [Related]
20. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.
Boardman F; Hale R
Mol Genet Genomic Med; 2018 Nov; 6(6):1079-1096. PubMed ID: 30370638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
